Bristol-Myers Squibb Co
NYSE:BMY
Bristol-Myers Squibb Co
NYSE:BMY
Price:
43.99 USD
0.66%
Market Closed
Updated:
May 4, 2024
Bristol-Myers Squibb Co
Other Operating Expenses
|
Bristol-Myers Squibb Co
Other Operating Expenses Peer Comparison
Comparables:
JNJ
PFE
MRK
ZTS
LLY
Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Operating Expenses | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other Operating Expenses
$2.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
57%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Other Operating Expenses
$1.7B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Pfizer Inc
NYSE:PFE
|
Other Operating Expenses
$1.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
6%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Zoetis Inc
NYSE:ZTS
|
Other Operating Expenses
-$1m
|
CAGR 3-Years
42%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Other Operating Expenses
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bristol-Myers Squibb Co's Other Operating Expenses?
Other Operating Expenses
2.2B
USD
2.2B
USD
Based on the financial report for Mar 31, 2024, Bristol-Myers Squibb Co's Other Operating Expenses amounts to 2.2B USD.
What is Bristol-Myers Squibb Co's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 10Y
57%
57%
Over the last year, the Other Operating Expenses growth was -10%. The average annual Other Operating Expenses growth rates for Bristol-Myers Squibb Co have been 15% over the past three years , 12% over the past five years , and 57% over the past ten years .
You don't have any saved screeners yet
